LUTRATE® Depot 22.5mg
3 Months
Leuprolide Acetate
Lutrate® Quarterly Depot (22.5 mg) is a new depot formulation of leuprorelin acetate, an LHRH agonist used for the treatment of advanced prostate cancer. The product has been developed based on proprietary technology owned by GP Pharm.
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling
